Abstract
Post-ischemic inflammation is re-appraised as an important player in the progression of ischemic stroke. Activation of inflammatory cells via Toll-like receptor 2 (TLR2) and TLR4 is caused by several damage-associated molecular patterns (DAMPs), including high mobility group box-1 (HMGB-1) and heat shock proteins. We have recently found that peroxiredoxin (Prx) is one of the strong DAMPs and activates infiltrating macrophages in brain ischemia. We have also found that interleukin-23 (IL-23) from the activated macrophages stimulates γδT cells which release IL-17, thereby causing the delayed expansion of infarct lesions. Further investigation of the innate immune response would lead to development of novel stroke treatment with a broad therapeutic time window.
Original language | English |
---|---|
Pages (from-to) | 573-578 |
Number of pages | 6 |
Journal | Nihon rinsho. Japanese journal of clinical medicine |
Volume | 74 |
Issue number | 4 |
Publication status | Published - 2016 Apr 1 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)